Endotronix Revenue and Competitors
Estimated Revenue & Valuation
- Endotronix's estimated annual revenue is currently $52.7M per year.
- Endotronix received $45.0M in venture funding in September 2018.
- Endotronix's estimated revenue per employee is $313,750
- Endotronix's total funding is $129.6M.
Employee Data
- Endotronix has 168 Employees.
- Endotronix grew their employee count by 25% last year.
Endotronix's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO, Co-founder | Reveal Email/Phone |
2 | VP Manufacturing and Operations | Reveal Email/Phone |
3 | VP Quality | Reveal Email/Phone |
4 | SVP Human Resources | Reveal Email/Phone |
5 | SVP Finance and Administration | Reveal Email/Phone |
6 | VP Clinical Operations | Reveal Email/Phone |
7 | EVP Clinical Affairs and Strategy | Reveal Email/Phone |
8 | Controller | Reveal Email/Phone |
9 | VP Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
10 | SVP, Marketing & Product Management | Reveal Email/Phone |
Endotronix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.5M | 46 | 0% | N/A | N/A |
What Is Endotronix?
Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.
keywords:Biotechnology,Enterprise Software,Health It,Healthcare,Medical Devices,Pharmaceuticals$129.6M
Total Funding
168
Number of Employees
$52.7M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Endotronix News
KG, Integrated Sensing Systems Inc., Dexcom, Senseonics Holdings Inc., Endotronix Inc., Orthosensor. The report provides a good overview of the key...
LISLE, Ill., March 2, 2021 /PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the appointment of seasoned medical device industry executive Dan Dearen to its Board of Directors. Mr. Deare ...
LISLE, IL – Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D financing round, bringing the total for the round to $70 million. The expansion syndicate for the LSP-led round includes new i ...
Boston Scientific, Endotronix, Inc., Integrated Sensing Systems, Inc., Ludwig Maximilians, niversitat Munich Company, NeuroVista Corporation, ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $28.6M | 179 | 5% | N/A |
#2 | $24.9M | 226 | 5% | N/A |
#3 | $37.3M | 234 | 7% | N/A |
#4 | $52.7M | 266 | N/A | N/A |
#5 | $86.8M | 272 | 10% | N/A |
Endotronix Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2014-05-01 | $1.6M | Undisclosed | Article | |
2015-02-18 | $0.3M | Undisclosed | Article | |
2016-01-06 | $3.0M | Undisclosed | Article | |
2016-07-15 | $32.0M | C | Multiple | Article |
2017-01-10 | $12.0M | C | Silicon Valley Bank | Article |
2018-02-27 | $37.0M | Undisclosed | Multiple | Article |
2018-09-17 | $45.0M | D | LSP | Article |